Chemical Component Summary

Name4-{[5-(cyclopropylcarbamoyl)-2-methylphenyl]amino}-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide
Identifiers4-[[5-(cyclopropylcarbamoyl)-2-methyl-phenyl]amino]-5-methyl-N-propyl-pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide
FormulaC22 H26 N6 O2
Molecular Weight406.481
TypeNON-POLYMER
Isomeric SMILESCCCNC(=O)c1cn2c(c1C)c(ncn2)Nc3cc(ccc3C)C(=O)NC4CC4
InChIInChI=1S/C22H26N6O2/c1-4-9-23-22(30)17-11-28-19(14(17)3)20(24-12-25-28)27-18-10-15(6-5-13(18)2)21(29)26-16-7-8-16/h5-6,10-12,16H,4,7-9H2,1-3H3,(H,23,30)(H,26,29)(H,24,25,27)
InChIKeyGDTQLZHHDRRBEB-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count56
Chiral Atom Count0
Bond Count59
Aromatic Bond Count16

Drug Info: DrugBank

DrugBank IDDB12696 
NameBMS-582949
Groups investigational
DescriptionBMS-582949 has been investigated for the treatment of Psoriasis.
SynonymsBMS-582949
CategoriesMitogen-Activated Protein Kinase 14, antagonists & inhibitors
CAS number623152-17-0

Related Resource References

Resource NameReference
Pharos CHEMBL1230065
PubChem 10409068
ChEMBL CHEMBL1230065